The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMID 16677808)

Published in Respir Med on May 04, 2006

Authors

N R Jørgensen1, P Schwarz, I Holme, B M Henriksen, L J Petersen, V Backer

Author Affiliations

1: Department of Clinical Biochemistry, Copenhagen University Hospital Hvidovre, DK-2650 Hvidovre, Denmark. niklas@dadlnet.dk

Associated clinical trials:

Breathing and Bones Initiative | NCT01161680

Articles citing this

Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med (2010) 2.60

Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 2.20

Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med (2009) 1.70

The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res (2011) 1.65

Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med (2013) 1.62

Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis (2014) 1.23

Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int (2007) 1.19

Falls in patients with chronic obstructive pulmonary disease: a call for further research. Respir Med (2009) 1.18

Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int (2009) 1.04

Prevalence and correlates of osteoporosis in chronic obstructive pulmonary disease patients in India. Lung India (2014) 1.03

Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function. J Bone Miner Metab (2014) 1.02

The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year. Int J Chron Obstruct Pulmon Dis (2009) 0.98

Low bone mineral density in men with chronic obstructive pulmonary disease. Respir Res (2011) 0.96

Association between use of benzodiazepines and risk of fractures: a meta-analysis. Osteoporos Int (2013) 0.95

Relationship between use of antidepressants and risk of fractures: a meta-analysis. Osteoporos Int (2012) 0.92

Plasma inflammatory mediators associated with bone metabolism in COPD. COPD (2010) 0.89

Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study. Osteoporos Int (2008) 0.88

Skeletal health in men with chronic lung disease: rates of testing, treatment, and fractures. Osteoporos Int (2010) 0.87

Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management. Semin Respir Crit Care Med (2015) 0.87

Comorbidity in chronic obstructive pulmonary disease. Related to disease severity? Int J Chron Obstruct Pulmon Dis (2014) 0.87

Impact of COPD exacerbations on osteoporosis assessed by chest CT scan. COPD (2012) 0.86

Long-term therapy in COPD: any evidence of adverse effect on bone? Int J Chron Obstruct Pulmon Dis (2009) 0.83

Is lung function associated with bone mineral density? Results from the Hertfordshire Cohort Study. Arch Osteoporos (2013) 0.83

The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2009) 0.82

Chronic Obstructive Pulmonary Disease Increases the Risk of Hip Fracture: A Nationwide Population-Based Cohort Study. Sci Rep (2016) 0.81

Hypoxia during sleep and the risk of falls and fractures in older men: the Osteoporotic Fractures in Men Sleep Study. J Am Geriatr Soc (2014) 0.81

Prevalence, risk factors, and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan. Int J Chron Obstruct Pulmon Dis (2015) 0.80

COPD and osteoporosis: links, risks, and treatment challenges. Int J Chron Obstruct Pulmon Dis (2016) 0.79

The relationship between pulmonary function and bone mineral density in healthy nonsmoking women: the Korean National Health and Nutrition Examination Survey (KNHANES) 2010. Osteoporos Int (2014) 0.78

The P2X7 receptor: a key player in immune-mediated bone loss? ScientificWorldJournal (2014) 0.78

Low bone mineral density in COPD patients with osteoporosis is related to low daily physical activity and high COPD assessment test scores. Int J Chron Obstruct Pulmon Dis (2015) 0.77

Effects of teriparatide on lung function and pain relief in women with multiple osteoporotic vertebral compression fractures. Surg Neurol Int (2014) 0.76

The effect of vitamin D on COPD exacerbation: a double blind randomized placebo-controlled parallel clinical trial. J Diabetes Metab Disord (2016) 0.75

The Skeletal Effects of Inhaled Glucocorticoids. Curr Osteoporos Rep (2016) 0.75

Osteoporosis Associated with Chronic Obstructive Pulmonary Disease. J Bone Metab (2016) 0.75

Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids. Osteoporos Int (2012) 0.75

Articles by these authors

(truncated to the top 100)

Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet (1981) 7.05

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet (2001) 6.31

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Benefit of a stroke unit: a randomized controlled trial. Stroke (1991) 3.13

The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med (1990) 2.85

Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women. BMJ (1999) 2.73

Coronary risk factors and socioeconomic status. The Oslo study. Lancet (1976) 2.67

Risk factors for sports injuries--a methodological approach. Br J Sports Med (2003) 2.59

Four-year mortality by some socioeconomic indicators: the Oslo study. J Epidemiol Community Health (1980) 2.48

Lung cancer and air pollution: a 27 year follow up of 16 209 Norwegian men. Thorax (2003) 2.43

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome. Scand J Gastroenterol (2004) 2.37

Type I collagen synthesis and degradation in peritendinous tissue after exercise determined by microdialysis in humans. J Physiol (1999) 2.32

Complement facilitates early prion pathogenesis. Nat Med (2001) 2.30

The Oslo study. Cardiovascular disease in middle-aged and young Oslo men. Acta Med Scand Suppl (1975) 2.30

Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension (1994) 2.28

Captured by art. Science (2001) 2.21

A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab (2012) 2.16

Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J (1997) 2.07

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer (1981) 2.06

Prevention of hamstring strains in elite soccer: an intervention study. Scand J Med Sci Sports (2007) 2.03

[Cytomegalovirus infection. A review]. Ugeskr Laeger (1993) 2.02

The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam. Spine (Phila Pa 1976) (1993) 2.01

Preventing injuries in female youth football--a cluster-randomized controlled trial. Scand J Med Sci Sports (2008) 1.90

Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79

Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet (1980) 1.75

Differences between echocardiographic measurements of left ventricular dimensions and function by local investigators and a core laboratory in a 2-year follow-up study of patients with an acute myocardial infarction. Eur J Echocardiogr (2002) 1.69

Transmission of scrapie by steel-surface-bound prions. Mol Med (2001) 1.63

Five-year mortality in the city of Bergen, Norway, according to age, sex and blood pressure. Acta Med Scand (1976) 1.60

Intravenous magnesium in acute myocardial infarction. Lancet (1986) 1.56

Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function. Eur Heart J (2002) 1.53

High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study. Br Med J (1978) 1.50

Characterization by biopsy or CEUS of liver lesions guided by image fusion between ultrasonography and CT, PET/CT or MRI. Ultraschall Med (2011) 1.50

Relationship between type 1 diabetes and atopic diseases in a twin population. Allergy (2010) 1.48

Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol (2006) 1.46

Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma. Arteriosclerosis (1990) 1.46

Determinants of vitamin D status in a general population of Danish adults. Bone (2011) 1.45

Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy. Clin Exp Allergy (2014) 1.44

Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem Pharmacol (1995) 1.42

Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study. Am J Med (1978) 1.42

Clopidogrel and the risk of osteoporotic fractures: a nationwide cohort study. J Intern Med (2012) 1.41

Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex. Thromb Haemost (1995) 1.41

[Risk factors for the development of asthma in children and adolescents. Results of a longitudinal study]. Ugeskr Laeger (1998) 1.39

[Doxazosin (Carduran)--a research survey]. Tidsskr Nor Laegeforen (1993) 1.39

The bronchial response to mannitol is attenuated by a previous methacholine test: but not vice versa. Clin Exp Allergy (2009) 1.39

Changing incidence and residual lifetime risk of common osteoporosis-related fractures. Osteoporos Int (1993) 1.39

Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem (1998) 1.37

Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol (1996) 1.37

Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations. Mov Disord (1994) 1.36

Oslo Study Diet and Antismoking Trial. Results after 102 months. Am J Med (1986) 1.35

Risk factors of stroke incidence and mortality. A 12-year follow-up of the Oslo Study. Stroke (1993) 1.31

A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax (1992) 1.29

Genetically improved potatoes: protection from damage by Colorado potato beetles. Plant Mol Biol (1993) 1.29

Ethnicity and sex are strong determinants of diabetes in an urban Western society: implications for prevention. Diabetologia (2005) 1.28

Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial. Diabetes Care (1997) 1.27

Association of cardiac autonomic function and the development of hypertension: the ARIC study. Am J Hypertens (1996) 1.26

Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial. Eur Respir J (2002) 1.23

Physical activity at work and at leisure in relation to coronary risk factors and social class. A 4-year mortality follow-up. The Oslo study. Acta Med Scand (1981) 1.22

Radial and humeral fractures as predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation. Osteoporos Int (1993) 1.22

Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma. Curr Med Res Opin (2004) 1.21

Estimates of asthma heritability in a large twin sample. Clin Exp Allergy (2010) 1.20

Combined diet and exercise intervention reverses the metabolic syndrome in middle-aged males: results from the Oslo Diet and Exercise Study. Scand J Med Sci Sports (2007) 1.19

Parathyroid hormone and bone healing. Calcif Tissue Int (2010) 1.18

Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care. J Intern Med (1998) 1.18

Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis (2010) 1.17

Acute effects of substance P and calcitonin gene-related peptide in human skin--a microdialysis study. J Invest Dermatol (2000) 1.17

Coronary risk factors in various occupational groups: the Oslo study. Br J Prev Soc Med (1977) 1.16

Inuit health in Greenland: a population survey of life style and disease in Greenland and among Inuit living in Denmark. Int J Circumpolar Health (2003) 1.16

Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men. Am J Epidemiol (1989) 1.16

Multivariate genetic analysis of atopy phenotypes in a selected sample of twins. Clin Exp Allergy (2006) 1.15

Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy (2007) 1.14

Possible metabolic side effects of beta-adrenergic blocking drugs. Br Med J (1978) 1.14

Partial characterization of virus-like particles in chloroplasts of plants infected with the U5 strain of TMV. Virology (1975) 1.13

Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J (1999) 1.13

Apoptosis of macrophages and T cells in tuberculosis associated caseous necrosis. J Pathol (2000) 1.12

Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells. Am J Physiol Endocrinol Metab (2003) 1.12

The Oslo Study: diet and antismoking advice. Additional results from a 5-year primary preventive trial in middle-aged men. Prev Med (1985) 1.12

New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased In vitro metabolic stability. J Med Chem (2000) 1.11

Efficient lymphoreticular prion propagation requires PrP(c) in stromal and hematopoietic cells. J Virol (2001) 1.10

Treatment of mild hypertension with diuretics. The importance of ECG abnormalities in the Oslo Study and in MRFIT. JAMA (1984) 1.10

High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study. Artery (1979) 1.09

Four and two-thirds years incidence of coronary heart disease in middle-aged men: the Oslo study. Am J Epidemiol (1980) 1.08

Acute meningococcal meningitis: analysis of features of the disease according to the age of 255 patients. Copenhagen Meningitis Study Group. J Infect (1997) 1.07

Different patterns of mast cell activation by muscle relaxants in human skin. Anesthesiology (2001) 1.05

Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia. Br J Psychiatry (2001) 1.05

Smoking habits and risk of fatal stroke: 18 years follow up of the Oslo Study. J Epidemiol Community Health (1996) 1.03

MAPHY and the two arms of HAPPHY. JAMA (1989) 1.01

Heredity in sarcoidosis: a registry-based twin study. Thorax (2008) 1.00

Environmental factors as a cause for the increase in allergic disease. Ann Allergy Asthma Immunol (2001) 0.99

Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr (2001) 0.99

Heavy resistance training increases muscle size, strength and physical function in elderly male COPD-patients--a pilot study. Respir Med (2004) 0.98

The intercorrelation of serum cholesterol, cigarette smoking and body weight. The Oslo Study. Acta Med Scand (1976) 0.97

Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology (1999) 0.97

[Mortality of Norwegian physicians in the period 1953-72 in relation to their smoking habits in 1952-3]. Tidsskr Nor Laegeforen (1976) 0.97

Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients. Clin Exp Allergy (2007) 0.97

Assessment of volar angulation and shortening in 5th metacarpal neck fractures: an inter- and intra-observer validity and reliability study. J Hand Surg Eur Vol (2012) 0.97

Changes in physical activity behavior and the development of body mass index during the last 30 years in Norway. Scand J Med Sci Sports (2007) 0.97

High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study. Blood Press Suppl (1992) 0.96

Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. J Clin Microbiol (2001) 0.96

Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial. Kidney Int (2001) 0.96

Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease. J Intern Med (2006) 0.95